FDA Paves Way For Pfizer COVID-19 Vaccinations For Kids Ages 5 To 11

The FDA has approved the emergency use of Pfizer's COVID-19 vaccine for children aged 5 to 11, making it available to 28 million kids in the US. This approval follows a quick process, with the FDA typically acting shortly after its advisory panel's recommendations. The CDC is expected to issue its own recommendations soon, potentially allowing vaccinations to begin as early as next week. The vaccine is reported to be 90% effective in protecting children from COVID-19, and while the approval process is fast, safety and efficacy remain priorities.

What is the expected timeline for children to start receiving the vaccine?

What does the FDA's quick approval process indicate about the vaccine's development?